KAZIA THERAPEUTICS LIMITED.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Novogen Completes the Private Placement of Equity 2015-04-29 15:32
Novogen Regains Full Compliance with NASDAQ Listing Rule 2015-04-28 11:48
Novogen Posts Details on Rights Issue Offering for Shareholders 2015-04-27 12:15
Cantrixil Receives Orphan Drug Designation from FDA 2015-04-22 12:29
Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 2015-04-21 11:34
Cantrixil Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer 2015-04-21 08:52
Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2015-04-17 09:43
Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma 2015-04-09 11:06
Novogen Engages Leading US Investor Relations Firm 2015-04-02 10:49
Yale University and Novogen Release Data on Cantrixil Mode of Action 2015-03-30 08:53
Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study 2015-03-19 04:00
Sky News, Helen Dalley interviews Dr Graham Kelly 2015-03-10 12:28
US Studies Confirm Ability of TRXE-009 to Kill Brain Cancer Stem Cells 2015-03-04 19:00
Novogen to Present at AusBiotech "Broker Meets Biotech" Event 2015-03-03 11:02
Novogen to Present at SACHS Cancer Bio Partnering & Investment Forum 2015-02-23 10:41
Novogen Investor Briefing Well Received 2015-02-20 04:47
Novogen to Hold Investor Briefing in New York 2015-02-17 19:07
Novogen Lodges Key Super-benzopyran Patent 2015-02-11 23:00
Novogen to present at BIO & CEO Investor Conference 9th & 10th February, 2015 2015-02-03 23:00
Novogen CEO to Present at Biotech and Money Conference in London 2015-01-23 17:00
1 3 4 5 6 7